Plaintiff Leadership Blames Social Media for “Mental Health Crisis” in Master Complaint

Plaintiff leaders in MDL 3047 directly accuse social media giants of intentionally targeting children with addictive algorithms to increase profits in the recently released Master Complaint. The 287-page document (included below) claims that the widespread use of addictive programs by children causes a “youth mental health crisis” and perpetuates the sexual exploitation of children.

The complaint alleges mismanagement and damages from children using Facebook, Instagram, Snapchat, TikTok, and YouTube and names parent companies Meta, Snap, ByteDance and Google as defendants. The JPML consolidated the case during a September 2022 meeting and transferred the case to the United States District Court for the District of California Northern under Judge Yvonne Gonzalez Rogers.

Johnson & Johnson Agrees to $8.9 Billion Talc Settlement

Johnson & Johnson, the world’s largest drugmaker, announced Tuesday it has agreed to settle tens of thousands of lawsuits against its asbestos-contaminated talcum powder products for $8.9 billion.

Juul Labs Settles Lawsuit With Chicago for Nearly a Quarter-Billion Dollars

E-cigarette maker Juul Labs Inc. settled a multimillion-dollar lawsuit with the city of Chicago this month, marking the latest in massive financial payouts from the once-thriving company.

Juul agreed to pay $23.8 million to settle a 2020 claim that it violated city ordinances by marketing and selling nicotine vaping products to Chicago’s youth. Juul denies any wrongdoing.

camp lejeune news 2023

Congress Approves $300 Billion In Compensation For Victims Of Camp Lejeune Toxic Water Contamination.

Camp Lejeune Lawsuit News and Updates

Our lawyers represent victims seeking a Camp Lejeune lawsuit in all 50 states. This page provides more comprehensive and updated information on Camp Lejeune claims than anywhere.

FDA Roundup: April 7, 2023

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

Today, the FDA issued a recall notice about Philips Respironics Recall Certain Reworked Dream Stations CPAP BiPAP machines for the risk they may deliver inaccurate or insufficient therapy. During initial programming, certain reworked Philips Dream Stations were assigned incorrect or duplicate serial numbers. This duplication can cause therapy to be delivered using the wrong prescription or factory default settings. Additionally, this duplication may fail to deliver any therapy at all. There is no warning or indication to the user that the DreamStation is not working as the doctor intended. The FDA has identified this as a Class I recall, the most severe recall. Use of these devices may cause serious injuries or death.